111 related articles for article (PubMed ID: 10782561)
21. Relationship of tissue plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen with coronary artery disease in South Indian male subjects.
Deepa R; Velmurugan K; Saravanan G; Dwarakanath V; Agarwal S; Mohan V
J Assoc Physicians India; 2002 Jul; 50():901-6. PubMed ID: 12126344
[TBL] [Abstract][Full Text] [Related]
22. Lipoprotein (a) as a determinant of arterial stiffness in elderly patients with type 2 diabetes mellitus.
Wakabayashi I; Masuda H
Clin Chim Acta; 2006 Nov; 373(1-2):127-31. PubMed ID: 16820145
[TBL] [Abstract][Full Text] [Related]
23. Lipoprotein (a) concentration and apolipoprotein (a) phenotype in subjects with type 2 diabetes mellitus.
Shi H; Fang J; Yang X; Shen Z; Zhu X
Chin Med J (Engl); 1998 Nov; 111(11):1013-7. PubMed ID: 11189206
[TBL] [Abstract][Full Text] [Related]
24. PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus.
Funk M; Endler G; Exner M; Marculescu R; Endler L; Abrahamian H; Mauler H; Grimm A; Raith M; Mannhalter C; Prager R; Irsigler K; Wagner OF
Wien Klin Wochenschr; 2005 Oct; 117(19-20):707-10. PubMed ID: 16416371
[TBL] [Abstract][Full Text] [Related]
25. Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications.
Colak E; Majkić-Singh N; Stanković S; Srecković-Dimitrijević V; Djordjević PB; Lalić K; Lalić N
Ann Med; 2005; 37(8):613-20. PubMed ID: 16338763
[TBL] [Abstract][Full Text] [Related]
26. [Lipoprotein (a) and ischemic heart diseases in patients with type 2 diabetes].
Ben Hamda K; Masmoudi AS; Mandhouj O; Hammami S; Attia N; Smaoui M; Zidi MA; Nabli N; Chaaba R; Mahjoub S; Ben Farhat M; Hammami M
Arch Inst Pasteur Tunis; 2002; 79(1-4):27-33. PubMed ID: 15072242
[TBL] [Abstract][Full Text] [Related]
27. Influence of endogenous and environmental factors on variations of serum lipoprotein (a) concentrations in a large population of insulin-treated diabetic patients.
Durlach V; Gillery P; Bertin E; Grulet H; Gross A; Leutenegger M
Diabetes Metab; 1998 Apr; 24(2):124-30. PubMed ID: 9592636
[TBL] [Abstract][Full Text] [Related]
28. Soluble CD40 ligand, plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor-1-antigen in normotensive type 2 diabetic subjects without diabetic complications. Effects of metformin and rosiglitazone.
Yener S; Comlekci A; Akinci B; Demir T; Yuksel F; Ozcan MA; Bayraktar F; Yesil S
Med Princ Pract; 2009; 18(4):266-71. PubMed ID: 19494532
[TBL] [Abstract][Full Text] [Related]
29. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
30. Lipoprotein(a), tissue plasminogen activator and plasminogen activator inhibitor 1 levels in hyperlipidaemic patients in Kuwait.
Akanji AO; Abdullah A; Tahzeeb S
Eur J Clin Invest; 1997 May; 27(5):380-6. PubMed ID: 9179544
[TBL] [Abstract][Full Text] [Related]
31. High levels of homocysteine, lipoprotein (a) and plasminogen activator inhibitor-1 are present in patients with abdominal aortic aneurysm.
Sofi F; Marcucci R; Giusti B; Pratesi G; Lari B; Sestini I; Lo Sapio P; Pulli R; Pratesi C; Abbate R; Gensini GF
Thromb Haemost; 2005 Nov; 94(5):1094-8. PubMed ID: 16363254
[TBL] [Abstract][Full Text] [Related]
32. The effect of rosiglitazone on novel atherosclerotic risk factors in patients with type 2 diabetes mellitus and hypertension. An open-label observational study.
Sarafidis PA; Lasaridis AN; Nilsson PM; Mouslech TF; Hitoglou-Makedou AD; Stafylas PC; Kazakos KA; Yovos JG; Tourkantonis AA
Metabolism; 2005 Sep; 54(9):1236-42. PubMed ID: 16125536
[TBL] [Abstract][Full Text] [Related]
33. [Plasminogen activator inhibitor (PAI-1) and markers of endothelial dysfunction in patients with diabetes mellitus].
Galajda P; Martinka E; Baláz D; Stasko J; Kerný J; Planková E; Mokán M; Kubisz P
Vnitr Lek; 1997 Nov; 43(11):744-7. PubMed ID: 9650506
[TBL] [Abstract][Full Text] [Related]
34. Determinants of plasminogen activator inhibitor-1 activity in survivors of myocardial infarction.
Gray RP; Mohamed-Ali V; Patterson DL; Yudkin JS
Thromb Haemost; 1995 Feb; 73(2):261-7. PubMed ID: 7792741
[TBL] [Abstract][Full Text] [Related]
35. Influence and interaction of diabetes and lipoprotein (a) serum levels on mortality of patients with peripheral artery disease.
Maca T; Mlekusch W; Doweik L; Budinsky AC; Bischof M; Minar E; Schillinger M
Eur J Clin Invest; 2007 Mar; 37(3):180-6. PubMed ID: 17359485
[TBL] [Abstract][Full Text] [Related]
36. Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus.
Murase T; Okubo M; Amemiya-Kudo M; Ebara T; Mori Y
Metabolism; 2008 Jun; 57(6):791-5. PubMed ID: 18502261
[TBL] [Abstract][Full Text] [Related]
37. Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients.
Ezzidi I; Mtiraoui N; Chaieb M; Kacem M; Mahjoub T; Almawi WY
Diabetes Metab; 2009 Jun; 35(3):214-9. PubMed ID: 19419896
[TBL] [Abstract][Full Text] [Related]
38. Nicotinamide effects oxidative burst activity of neutrophils in patients with poorly controlled type 2 diabetes mellitus.
Osar Z; Samanci T; Demirel GY; Damci T; Ilkova H
Exp Diabesity Res; 2004; 5(2):155-62. PubMed ID: 15203886
[TBL] [Abstract][Full Text] [Related]
39. Association of serum lipoprotein (a) with hypertension in diabetic patients.
Nasri H
Saudi J Kidney Dis Transpl; 2008 May; 19(3):420-7. PubMed ID: 18445903
[TBL] [Abstract][Full Text] [Related]
40. Fibrinolytic dysfunction after gestation is associated to components of insulin resistance and early type 2 diabetes in latino women with previous gestational diabetes.
Morimitsu LK; Fusaro AS; Sanchez VH; Hagemann CC; Bertini AM; Dib SA
Diabetes Res Clin Pract; 2007 Dec; 78(3):340-8. PubMed ID: 17544539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]